期刊文献+

CLAG方案治疗ETO阴性合并CEBPA突变WT1阳性急性髓系白血病M2一例并文献复习

Acute myeloid leukemia M2 patient with negative ETO combined with CEBPA mutation and positive WT1 treated by CLAG regimen: report of one case and review of literature
原文传递
导出
摘要 目的观察CLAG方案治疗ETO阴性合并CEBPA突变WT1阳性急性髓系白血病(AML)M2的临床疗效。方法对兰州军区兰州总医院1例采用CLAG方案治疗的ETO阴性合并CEBPA突变WT1阳性AML-M2患者的诊疗情况进行分析,并复习相关文献。结果该例患者行IA方案化疗1个疗程后未获得缓解,改行CLAG方案化疗1个疗程,复查骨髓完全缓解,后转外院进一步治疗。结论CLAG方案治疗ETO阴性合并CEBPA突变WT1阳性AML-M2患者短期疗效良好,长期疗效仍需积累更多的病例进一步观察。
作者 曹红刚 吴涛 薛锋 汉英 王存邦 白海 Cao Honggang;Wu Tao;Xue Feng;Han Ying;Wang Cunbang;Bai Hai(Department of Hematology, Lanzhou General Hospital, Lanzhou Command, Lanzhou 730050, China;Health Center of Beichengpu Town in Tongwei County of Gansu Province, Dingxi 743323, China)
出处 《白血病.淋巴瘤》 CAS 2019年第9期554-556,共3页 Journal of Leukemia & Lymphoma
基金 甘肃省自然科学基金(145RJZA151).
  • 相关文献

参考文献3

二级参考文献63

  • 1Cohen A,Hirschhorn R,Horowitz SD,et al.Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.Proc Natl Acad Sci USA,1978,75(1):472-476.
  • 2Carson DA, Wasson DB, Kaye J, et al. Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo.Proc Natl Acad Sci USA,1980,77(11):6865-6869.
  • 3Sigal DS,Miller HJ, Schram ED,et al.Beyond hairy cell: the activity of cladribine in other hematologic malignancies.Blood,2010,11616):2884 -2896.
  • 4Torrey ML, Sigal DS, Saven A.Development of cladribine at Scripps for hairy cell leukemia and current results.Leuk Lymphoma,2011,52(2):29-33.
  • 5Robak T, Jamroziak K,Gora-Tybor J,et al.Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a pmspective,ra ndomized,multicenter trisl.Blood,2007,109(9):3672-3675.
  • 6Tallman MS,Zakarija A.Hairy cell leukemia: survival and relapse.Long-term follow-up of purine anaiog-based therapy and approach for relapsed disease. Transfus Apher Sci,2005,32(1): 99-103.
  • 7Goodman GR,Burian C,Koziol JA,et al. Extended follow-up of patients with hairy cell leukemia after treatment with cladribine.J Clin Oncol,2003,21(5): 891-896.
  • 8Seymour JF, Kurzrock R,Freireich EJ,et al.2- chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia.Blood, 1994,83(10):2906- 2911.
  • 9Tadmor T.Purine analog toxicity in patients with hairy cell leukemia.Leuk Lymphoma,2011,52 (Suppl 2):38-42.
  • 10Else M,Dearden CE,Matutes E,et ai.Long-term follow-up of 233 patients with hairy cell leukaemia,treated initially with pentostatin or cladribine,at a median of 16 years from diagnosis.Br J Haematol, 2009,145(6):733-740.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部